会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 15. 发明授权
    • Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
    • 基于α-酮氧化物化合物的组蛋白脱乙酰酶抑制剂
    • US07579372B2
    • 2009-08-25
    • US11198293
    • 2005-08-08
    • Hsuan-Yin Lan-HargestRobert J. Kaufman
    • Hsuan-Yin Lan-HargestRobert J. Kaufman
    • A61K31/336
    • C07D303/32
    • Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, for example, an alpha-ketoepoxide group, such as an alpha-ketothio group, can inhibit histone deacetylase. Histone deacetylase inhibition can repress gene expression, including expression of genes related to tumor suppression. Accordingly, inhibition of histone deacetylase can provide an alternate route for treating cancer, hematological disorders, e.g., hemoglobinopathies, autosomal dominant disorders, e.g. spinal muscular atrophy and Huntington's disease, genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy, or to stimulate hematopoietic cells ex vivo.
    • 组蛋白脱乙酰酶是在活性位点具有锌的金属酶。 具有锌结合部分的化合物,例如α-酮氧化物基团,例如α-酮硫基,可以抑制组蛋白脱乙酰酶。 组蛋白脱乙酰酶抑制可抑制基因表达,包括与肿瘤抑制相关的基因的表达。 因此,组蛋白脱乙酰酶的抑制可以提供治疗癌症的替代途径,血液学病症,例如血红蛋白病,常染色体显性疾病,例如常染色体显性疾病。 脊髓性肌肉萎缩和亨廷顿病,遗传相关的代谢紊乱,例如囊性纤维化和肾上腺脑白质营养不良,或离体刺激造血细胞。
    • 19. 发明授权
    • Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
    • 基于α-酮氧化物化合物的组蛋白脱乙酰酶抑制剂
    • US08138225B2
    • 2012-03-20
    • US12545712
    • 2009-08-21
    • Hsuan-Yin Lan-HargestRobert J. Kaufman
    • Hsuan-Yin Lan-HargestRobert J. Kaufman
    • A61K31/336
    • C07D303/32
    • Histone deacetylase is a metallo-enzyme with zinc at the active site. Compounds having a zinc-binding moiety, for example, an alpha-ketoepoxide group, such as an alpha-ketothio group, can inhibit histone deacetylase. Histone deacetylase inhibition can repress gene expression, including expression of genes related to tumor suppression. Accordingly, inhibition of histone deacetylase can provide an alternate route for treating cancer, hematological disorders, e.g., hemoglobinopathies, autosomal dominant disorders, e.g. spinal muscular atrophy and Huntington's disease, genetic related metabolic disorders, e.g., cystic fibrosis and adrenoleukodystrophy, or to stimulate hematopoietic cells ex vivo.
    • 组蛋白脱乙酰酶是在活性位点具有锌的金属酶。 具有锌结合部分的化合物,例如α-酮氧化物基团,例如α-酮硫基,可以抑制组蛋白脱乙酰酶。 组蛋白脱乙酰酶抑制可抑制基因表达,包括与肿瘤抑制相关的基因的表达。 因此,组蛋白脱乙酰酶的抑制可以提供治疗癌症的替代途径,血液学病症,例如血红蛋白病,常染色体显性疾病,例如常染色体显性疾病。 脊髓性肌肉萎缩和亨廷顿病,遗传相关的代谢紊乱,例如囊性纤维化和肾上腺脑白质营养不良,或离体刺激造血细胞。